학술논문
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial
Document Type
Article
Author
Sharman, J.P.; Egyed, M.; Jurczak, W.; Skarbnik, A.; Pagel, J.M.; Flinn, I.W.; Kamdar, M.; Munir, T.; Walewska, R.; Corbett, G.; Fogliatto, L.M.; Herishanu, Y.; Banerji, V.; Coutre, S.; Follows, G.; Walker, P.; Karlsson, K.; Ghia, P.; Janssens, A.; Cymbalista, F.; Woyach, J.A.; Byrd, J.C.; Salles, G.; Wierda, W.G.; Izumi, R.; Munugalavadla, V.; Patel, P.; Wang, M.H.; Wong, S.
Source
In: The Lancet . (The Lancet, 18 - 24 April 2020, 395(10232):1278-1291)
Subject
Language
English
ISSN
1474547X
01406736
01406736